Label Value
DOI 10.1186/2051-1426-3-S2-P341
TITLE Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients
TYPE article
PUBLICATION DATE
Service Status Date Last Checked
Scopus No 2021-06-14T02:52:20.945882
Web of Science No 2021-06-16T04:08:45.133144
Compendex No 2020-10-15T20:01:22.039785